Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CQ6J | ISIN: CA62857B1094 | Ticker-Symbol:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MYND LIFE SCIENCES INC Chart 1 Jahr
5-Tage-Chart
MYND LIFE SCIENCES INC 5-Tage-Chart

Aktuelle News zur MYND LIFE SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.05.CSE Bulletin: Suspension - MYND Life Sciences Inc. (MYND)206Toronto, Ontario--(Newsfile Corp. - Le 1 mai/May 2025) - Effective immediately, MYND Life Sciences Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined...
► Artikel lesen
01.05.Mynd Life Sciences Inc: Mynd Life Sciences halted at the open2
10.04.Mynd Life Sciences Inc: Mynd has no material changes1
09.04.MYND Life Sciences Inc.: Management Cease Trade Order Status Report304Vancouver, British Columbia--(Newsfile Corp. - April 9, 2025) - Mynd Life Sciences Inc. (CNSX: MYND) ("Mynd" or the "Company") announced on March 3, 2025 the Company was granted a management cease...
► Artikel lesen
25.03.Mynd Life Sciences Inc: Mynd working to file fiscal 2024 results by April 291
MYND LIFE SCIENCES Aktie jetzt für 0€ handeln
25.03.MYND Life Sciences Inc.: Management Cease Trade Order Status Report806Vancouver, British Columbia--(Newsfile Corp. - March 24, 2025) - MYND Life Sciences Inc. (CSE: MYND) ("MYND" or the "Company") announced on March 3, 2025, the Company was granted a management cease...
► Artikel lesen
04.03.Mynd Life Sciences Inc: Mynd late to file fiscal 2024 results, receives MCTO1
04.03.MYND Life Sciences Inc.: Management Cease Trade Order Granted421Vancouver, British Columbia--(Newsfile Corp. - March 3, 2025) - Mynd Life Sciences Inc. (CNSX: MYND) ("Mynd" or the "Company") announces that it has been advised by its external auditors (the "Auditors")...
► Artikel lesen
12.02.Mynd Life Sciences Inc: Mynd Life to issue 22.73 million shares for debt1
12.02.MYND Life Sciences Inc.: MYND Life Sciences Announces Shares for Debt Transaction454Vancouver, British Columbia--(Newsfile Corp. - February 11, 2025) - MYND Life Sciences Inc. (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed...
► Artikel lesen
18.01.Mynd Life Sciences Inc: Mynd Life Sciences issues four million shares1
18.01.MYND Life Sciences Inc.: MYND Life Sciences Announces the Issuance of 4,000,001 Shares at $0.71/share949Vancouver, British Columbia--(Newsfile Corp. - January 17, 2025) - MYND Life Sciences (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the...
► Artikel lesen
10.01.Mynd Life Sciences Inc: Mynd completes $3.5-million debenture settlement1
10.01.MYND Life Sciences Inc.: MYND Life Sciences Announces Successful Conclusion of Debenture Settlement Agreement and Leadership Transition385Vancouver, British Columbia--(Newsfile Corp. - January 10, 2025) - MYND Life Sciences (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the...
► Artikel lesen
23.11.24MYND Life Sciences Inc.: MYND Life Sciences Announces Strategic Debt Reduction and New Board Member Appointment907Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a leader in mental health diagnostics and treatments, today...
► Artikel lesen
13.11.24MYND Life Sciences Inc.: MYND Life Sciences Announces Proposed Share Issuance to Remove Debenture and $3.440 M in debt on business431Vancouver, British Columbia--(Newsfile Corp. - November 12, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the development...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1